Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

AMR and Bristol-Myers Squibb patent discloses new agents for ADHD

Feb. 21, 2007

Heat shock protein 90 inhibitor shows promise for Alzheimer's disease in preclinical studies

Feb. 21, 2007

CAM-2028 cleared to begin phase II oral mucositis study

Feb. 21, 2007

BTG inlicenses opioid agonist for postoperative pain

Feb. 21, 2007

Phase III results demonstrate efficacy of M6G in patients with postoperative pain

Feb. 21, 2007

Cognitive and mood improvement after guarana therapy reported

Feb. 20, 2007

New agents for treating neurological disorders disclosed in recent patents

Feb. 20, 2007

Pipex Pharmaceuticals' Coprexa awarded NIH grant for Alzheimer's disease

Feb. 20, 2007

KeyNeurotek and Max-Planck sign licensing agreement

Feb. 20, 2007

Valeant acquires rights to nabilone in the U.K. and Europe

Feb. 20, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...